- ►diabetesjournals.org HC Yeh, NM Punjabi, NY Wang, JS Pankow, BB … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—At baseline, adults with diabetes had significantly lower predicted
FVC (96 vs. 103%, P < 0.001) and predicted FEV 1 (92 vs. 96%, P < 0.001) than
those without diabetes. These differences remained significant after ... Cited by 14 - Related articles - BL Direct - All 7 versions
SK Garg, C Mathieu, N Rais, H Gao, JA … - Diabetes technology & therapeutics, 2009 - liebertonline.com Abstract Background: Patients with type 1 diabetes require intensive insulin
therapy for optimal glycemic control. AIRÒ inhaled insulin (system from Eli
Lilly and Company, Indianapolis, IN) (AIR is a registered trademark of ... Cited by 5 - Related articles - All 4 versions
E Ang, MK Lawrence, CR Heilmann, JA … - Diabetes Technology & Therapeutics, 2009 - liebertonline.com Abstract Background: Long-term safety and efficacy of AIRÒ inhaled insulin (Eli
Lilly and Co., Indianapolis, IN) (AIR is a registered trademark of Alkermes,
Inc., Cambridge, MA) in patients with diabetes and concomitant lung disease ... Cited by 1 - Related articles - All 2 versions
RM Bergenstal, N Freemantle, M Leyk, GB … - Diabetes Technology & Therapeutics, 2009 - liebertonline.com Abstract Background: In the concordance model, physician and patient discuss
treatment options, explore the impact of treatment decisions from the patient's
perspective, and make treatment choices together. We tested, in a con- ... Cited by 1 - Related articles - All 2 versions
[CITATION] Last literature review for version 16.3: Wed Oct 01 00: 00: 00 GMT 2008| This topic last …